The Strategic Committee for Special Innovation (CEIE) in Health proposed the development of new medical devices that could enable the configuration of hybrid operating rooms — surgical spaces equipped for high resolution radiodiagnostic imaging, virtual reality, 3D printing, and others. technology vocabulary. -. The objective is to carry out proper surgeries that “promote the rapid recovery of the patient.”
This was said by a team of specialists who, in the second meeting of the Valencian Innovation Agency (AVI), advises them to face the challenges of this knowledge, as indicated in the general presentation.
Specifically, the experts identified twelve proposals for innovation to address the primary challenges of the health system and also to encourage the consolidation of the productive health system.
Likewise, the effective implementation of personalized medicine is one of the goals of the commission, which commits to the development of digital twins based on clinical data exploration, to reproduce the operation of human organs and the detection of pathologies, as well as the design of a new diagnostic methodology based on biomarkers.
Along these same lines, the team is driving progress in the prototyping of miniaturized cellular tissues in the laboratory that mimic organs to test the response to advanced therapies, a design of tests capable of certifying the reliability, efficiency and biosafety of innovative drugs. the development of tools that allow the implementation of monitoring, control, production and industrial processes for these drugs.
In order to prevent, identify and control mental problems and chronic diseases, the physicist María Jesús Vicent, from the Príncipe Felipe Research Center (CIPF), advocated the development and integration of artificial intelligence and the development and integration of big data tools, as well as others. information systems to undertake predictive analysis. Detection of pathogens in the health environment
In the same way, the project maintained its concern about the incidence of hospital infections and proposed solutions for the detection and identification in real time of pathogenic aerosols in the health environment, the development of more efficient air purification systems and new strategies. tools and equipment to enhance the health of professionals.
Maria Jesús Vicent, for her part, gave herself the challenge of promoting projects in the assembly within a maximum period of three years. Also, new opportunities in the first part of the work in the first part of the doctor moved.
“In the Community of Valencia there are bases for the creation of a business device suitable for providing additional services in the development process and the use of advanced therapies and medicines,” he explained. CITY SCIENCES, ARTISTIC INSTITUTIONS AND BUSINESSES
The multidisciplinary team is made up of representatives of the scientific community, technological organizations and the business community, as well as health professionals who will be the end users of these innovations.
The plan includes participation from the scientific sphere Cristina Botella (Universität Jaume I), Salvador Martínez, (Institute of Neuroscience), Josep Redón (Incliva Health Research Institute) and Damià Tormo (Columbus Foundation), in addition to Javier Sánchez. from the Biomechanics Institute of Valencia (IBV) as part of the technology centers.
The manufacturer is represented by Mara Gracia (Surgival), Francisco Sánchís (Elix Pharma) and José Manuel Santabárbara (Ascires Group), as well as José María Lagarón (Bionicia), who is one of the new members of the team. The second innovation falls on Esther Soler (Elche General Hospital), who joins Maria Isabella Acién (San Juan de Alicante Hospital), to provide the vision and needs of health professionals.
It is expected that in the next few weeks, this working group will give its final conclusions, which will be available to all agents involved in the Valencian Innovation System after being validated by the Strategic Innovation Committee (CEI).
For its part, AVI begins to prioritize, as of 2024, those R+D+i projects that involve the development and implementation of these projects, within the scope of its call to help in competitive competition.
